natgillin/translations-raw huggingface dataset:
The Commission has proposed a new, ambitious stand-alone health programme for the 2021-2027 period - the EU4Health Programme.
Komisija je predlagala nov ambiciozen samostojni zdravstveni program za obdobje 2021-2027, tj.
With the adoption of the EU4Health programme, the Commission is adapting its proposal for the European Social Fund Plus (ESF+), fully integrating its health strand into the EU4Health Programme.
S sprejetjem Programa EU za zdravje je Komisija prilagodila svoj predlog za Evropski socialni sklad plus (ESF+) in njegov sklop za zdravje v celoti vključila v ta program.
How much funding will be available under the EU4Health programme and how will it be spent?
Koliko sredstev bo na voljo v okviru Programa EU za zdravje in kako bodo porabljena?
These include but are not limited to:
Med temi ukrepi so:
What is the difference between the stockpiling under EU4health and the rescEU capacities programme?
Kakšna je razlika med ustvarjanjem zalog v okviru Programa EU za zdravje in zmogljivostmi v okviru programa rescEU?
Does EU4Healthrespect Member States' competence in health?
Ali Program EU za zdravje upošteva pristojnost držav članic na področju zdravja?
EU4Health will work with Member States, respecting the division of competences in health policy set out in Article 168 of the Treaty on the Functioning of the European Union (TFEU), and drawing on existing cooperation mechanisms, focusing on strategic and cross-border aspects.
Delo v okviru Programa EU za zdravje bo potekalo v sodelovanju z državami članicami, pri čemer se bo upoštevala razdelitev pristojnosti na področju zdravstvene politike iz člena 168 Pogodbe o delovanju Evropske unije (PDEU), in na podlagi obstoječih mehanizmov sodelovanja ob osredotočanju na strateške in čezmejne vidike.
How will EU4Health be implemented and what will be the role of EU agencies?
Kako se bo izvajal Program EU za zdravje in kakšna bo vloga agencij EU?
The EU Reference Networks (ERNs) for rare, low prevalence and complex diseases, will be expanded to cover other rare non-communicable as well as infectious diseases, allowing medical knowledge and expertise to travel rather than the patients.
Referenčne mreže EU za redke bolezni, bolezni z nizko prevalenco in kompleksne bolezni bodo razširjene ter bodo vključevale še več redkih nenalezljivih bolezni in infekcijskih bolezni, kar bo omogočilo potovanje medicinskega in strokovnega znanja in izkušenj namesto potovanja pacientov.
create a reserve of healthcare staff and experts that can be mobilised to prevent or respond to health crises throughout the EU;
vzpostavila seznam zdravstvenega osebja in strokovnjakov, ki se lahko mobilizirajo za preprečevanje zdravstvenih kriz v EU ali odzivanje nanje;
EU4Health will support disease prevention (including screening and early diagnosis) and health promotion programmes in Member States.
Program EU za zdravje bo podpiral programe za preprečevanje bolezni (vključno s presejalnimi pregledi in zgodnjim diagnosticiranjem) ter programe za spodbujanje zdravja v državah članicah.
Horizon Europe will finance research and innovation on topics such as life-long good health; environmental and social health determinants; non-communicable and rare diseases; infectious diseases; tools, technologies and digital solutions for health and care and healthcare systems.
Program Obzorje Evropa bo financiral raziskave in inovacije na področjih, kot so vseživljenjsko dobro zdravje, okoljski in družbeni dejavniki zdravja, nenalezljive in redke bolezni, infekcijske bolezni, orodja, tehnologije in digitalne rešitve za zdravje, zdravstveno oskrbo in sisteme zdravstvenega varstva.
This new programme will also fill the gaps revealed by the COVID-19 crisis and ensure that EUs health systems are resilient enough to face new and future health threats.
Ta novi program bo zapolnil tudi vrzeli, ki jih je razkrila koronavirusna kriza, ter zagotovil, da bodo zdravstveni sistemi EU dovolj odporni proti tem novim in prihodnjim nevarnostim za zdravje.
The EU4Health Programme will help to ensure best use of research results and facilitate the uptake, scale-up and deployment of health innovation in healthcare systems and clinical practice.
Program EU za zdravje bo pomagal zagotoviti najboljšo uporabo rezultatov raziskav ter olajšal uvedbo, razširitev in uporabo zdravstvenih inovacij v sistemih zdravstvenega varstva in klinični praksi.
Non-communicable diseases as cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, represent major causes of disability, ill-health, health-related retirement, and premature death in the Union, resulting in considerable social and economic costs.
Nenalezljive bolezni, kot so bolezni srca in ožilja, rak, kronične bolezni dihal in sladkorna bolezen, so glavni vzroki za invalidnost, zdravstvene težave, upokojitve iz zdravstvenih razlogov in prezgodnje smrti v Uniji, kar je povezano s precejšnjimi socialnimi in ekonomskimi stroški.
Whilst the EU4Health is the most ambitious health programme ever, important investments in health in the next long-term budget will also be made through other funding instruments working in synergy with EU4Health:
Čeprav je Program EU za zdravje najbolj ambiciozen zdravstveni program do zdaj, bodo v naslednjem dolgoročnem proračunu za področje zdravja namenjena znatna finančna sredstva tudi prek drugih instrumentov financiranja, ki delujejo v sinergiji s Programom EU za zdravje, in sicer:
EU4Health will work closely with the EU's main research and innovation programme, Horizon Europe, which includes a health cluster.
Program EU za zdravje bo tesno sodeloval z glavnim programom EU za raziskave in inovacije, tj. programom Obzorje Evropa, ki vključuje sklop za zdravje.
obstacles to the wide uptake and best use of digital innovations as well their scaling up;
ovire za večje uvajanje digitalnih inovacij in njihovo najboljšo uporabo ter razširjanje;
Country-specific tailor made support and advice to countries, or groups of countries, with the highest needs, through twinning, expert advice and peer support, etc;
prilagojena pomoč in svetovanje posameznim državam ali skupinam držav z največjimi potrebami prek tesnega medinstitucionalnega sodelovanja, strokovnega svetovanja in medsebojne podpore itd.;
train healthcare professionals for deployment across the EU;
usposabljala zdravstvene delavce za napotitve znotraj EU;
burden from non-communicable diseases, in particular cancer, mental health, rare diseases and risks from health determinants;
breme zaradi nenalezljivih bolezni, zlasti raka, duševnih motenj, redkih bolezni in tveganj, povezanih z dejavniki zdravja;
EU4Health will make a significant contribution to the post-COVID-19 recovery by making the EU population healthier, strengthening the resilience of health systems, and promoting innovation in the health sector.
Program EU za zdravje bo pomembno prispeval k okrevanju po koronavirusni krizi s prizadevanji za bolj zdravo prebivalstvo EU, krepitvijo odpornosti zdravstvenih sistemov in spodbujanjem inovacij v zdravstvenem sektorju.
When will the EU4Health funding become available?
Kdaj bo finančna sredstva za Program EU za zdravje na voljo?
2. making medicines, medical devices and other crisis relevant products, available and affordable and supporting innovation;
2. zagotavljanje razpoložljivosti in cenovne dostopnosti zdravil, medicinskih pripomočkov in drugih v krizi pomembnih izdelkov ter podpiranje inovacij;
This is compared to the previous Commission proposal for a health strand under the European Social Fund+ of €413 million.
Komisija v okviru Programa EU za zdravje predlaga naložbe v krepitev zdravstvenih sistemov v višini 9,4 milijarde evrov, medtem ko je bilo v prejšnjem predlogu Komisije za sklop za zdravje v okviru Evropskega socialnega sklada plus predvidenih 413 milijonov evrov.
New EU4Health Programme
Program EU za zdravje.
Given the current crisis, there is no time to lose.
Glede na sedanjo krizo ne moremo več izgubljati časa.
How much money has been raised so far?
Koliko denarja je bilo zbranega doslej?
More are expected to join.
Predvidoma se jih bo pridružilo še več.
How will the three partnerships work?
Kako bodo ta tri partnerstva delovala?
The following distribution summarises the amounts allocated to global health organisations:
V naslednji razdelitvi so povzeti zneski, dodeljeni globalnim zdravstvenim organizacijam:
Together, they develop the agenda and co-implement the work needed.
Skupaj bodo razvili agendo in izvajali potrebno delo.
This will require significant funding.
Za to bodo potrebna znatna finančna sredstva;
Questions and answers: the Coronavirus Global response
Vprašanja in odgovori: globalni odziv na koronavirus
It will capitalise on the expertise of existing institutions and partners and not establish any no new structures or institutions.
Izkoristila bo strokovno znanje obstoječih institucij in partnerjev ter zato ne bo pomenila nobenih novih struktur ali institucij.
The ACT-Accelerator framework will report to the global community on:
Okvir pospeševalnika ACT bo svetovni skupnosti poročal glede:
The structure will be in place for two years (renewable).
Struktura bo vzpostavljena za dve leti (z možnostjo podaljšanja).
At least €700 million for national COVID-19 research project.
vsaj 700 milijonov evrov za nacionalne raziskovalne projekte na področju COVID-19.
Therapeutics: So far, more than 40 developers of potential treatments for coronavirus have contacted the European Medicines Agency (EMA) and the Member States for scientific advice.
terapevtika: doslej se je več kot 40 razvijalcev morebitnih zdravljenj koronavirusa obrnilo na Evropsko agencijo za zdravila (EMA) in države članice za znanstveno svetovanje.
The core of the framework is the three partnerships based on each of the three priorities.
Jedro okvira tvorijo tri partnerstva, vsako od njih pa temelji na enem od treh prednostnih področij.
A Gavi replenishment summit takes place on 4 June 2020 in London.
Vrh o dopolnitvi sredstev za Gavi bo 4. junija 2020 v Londonu.
Currently, there are more than 100 vaccines in development, and around 10 have entered into clinical trials.
Trenutno je v razvoju več kot 100 cepiv, s približno desetimi pa poteka klinično preskušanje.
Raising €7.4 billion was an extraordinary achievement but it will not be enough to ensure the distribution of coronavirus health technologies worldwide, as this involves significant costs in terms of production, procurement and distribution.
Zbrati 7,4 milijarde evrov je bil izjemen dosežek, vendar ne bo zadoščal, da bi zagotovili distribucijo zdravstvenih tehnologij na področju koronavirusa po vsem svetu, saj to zajema znatne stroške v smislu proizvodnje, nabave in distribucije.
Funding will benefit organisations that strive to ensure that the products will be available, accessible and affordable across the world, especially in the most vulnerable countries.
Financiranje bo koristilo organizacijam, ki si prizadevajo zagotoviti, da bodo izdelki na voljo, cenovno ugodni in dostopni po vsem svetu, zlasti v najbolj ranljivih državah.
€15.7 million through the Global Fund to Fight AIDS, Tuberculosis and Malaria.
15,7 milijonov evrov Globalnemu skladu za boj proti aidsu, tuberkulozi in malariji;
€2.6 billion through the World Health Organization (WHO), for health systems strengthening.
2,6 milijarde evrov Svetovni zdravstveni organizaciji (SZO) za krepitev zdravstvenih sistemov;
The European Investment Bank has pledged €2 billion, including €141 million pledged on 4 May.
Evropska investicijska banka se je zavezala, da bo prispevala 2 milijardi evrov, vključno s 141 milijoni evrov, doniranimi 4. maja.
Where are the main needs in the areas of vaccines, therapeutics and diagnostics?
Kje so glavne potrebe na področju cepiv, terapevtike in diagnostike?
Its three main missions are:
Tri glavne naloge okvira sodelovanja so:
What is the estimated timeline for delivery on the three strands?
Kakšen je predvideni časovni ovir za doseganje rezultatov na vseh treh področjih?
The WHO will also lead the work on product allocation across the 3 partnerships.
Svetovna zdravstvena organizacija bo vodila tudi delo na področju razdeljevanja izdelkov v okviru treh partnerstev.
Once a vaccine is available, the challenge will be to produce it in the extremely high quantities needed and required, as well as to ensure that it is available and accessible for all countries, including low and medium-income countries.WHO keeps track of all candidate vaccines at https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines .
Ko bo cepivo na voljo, bo izziv, kako ga proizvesti v izjemno velikih količinah, ki so potrebne in nujne, ter kako zagotoviti, da bo cepivo na voljo in dostopno za vse države, tudi države z nizkimi in srednje visokimi dohodki.SZO beleži vsa morebitna cepiva na: https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines ;
Furthermore, donors decided to pay special attention to strengthening of health systems with €4.3 billion (45.5% of the pledges).
Poleg tega so se donatorji odločili, da bodo posebno pozornost namenili krepitvi zdravstvenih sistemov, in bodo temu cilju namenili 4,3 milijarde evrov (45,5 % donacij).
The prioritisation of health systems strengthening by donors reflects a reality: in many countries, unequipped health systems represent the major bottleneck for accessing health innovations and preventing new outbreaks.
Dejstvo, da donatorji dajejo prednost krepitvi zdravstvenih sistemov, odraža realnost: v številnih državah so slabo opremljeni zdravstveni sistemi glavno ozko grlo pri dostopu do inovacij na področju zdravja in preprečevanju novih izbruhov.
€2.3 billion (23.5%) were allocated to vaccines, €814 million to therapeutics (8%), and €242 million (2.5%) to diagnostics.
Za cepiva je bilo dodeljenih 2,3 milijarde evrov (23,5 %), za terapevtiko 814 milijonov evrov (8 %), za diagnostiko pa skoraj 242 milijonov evrov (2,5 %).
The remaining amount of €2.1 billion (21.5%) includes un-earmarked pledges, unallocated pledges, or pledges allocated to other coronavirus projects, including for humanitarian assistance, emergencies, or coronavirus national research programmes (€700 million).
Preostali znesek v višini 2,1 milijarde evrov (21,5 %) vključuje nenamenske donacije, nedodeljene donacije ali donacije za druge projekte v zvezi s koronavirusom, vključno za humanitarno pomoč, izredne razmere ali nacionalne raziskovalne programe na področju koronavirusa (700 milijonov evrov).
For publicly funded research, there should be open access to results, i.e. data, knowledge and to intellectual property to the extent needed to ensure global deployment and access.
Dostop do rezultatov javno financiranih raziskav, tj. do podatkov, znanja in intelektualne lastnine, bi moral biti odprt v obsegu, ki je potreben za zagotovitev globalnega uvajanja in dostopa.
The universal and affordable access to COVID-19 Tools (ACT) was the main objective of the 24 April call to action from the global health partners.
Univerzalen in cenovno ugoden dostop do orodij za COVID-19 je bil glavni cilj poziva k ukrepanju, ki so ga 24. aprila objavili svetovni zdravstveni partnerji.
Coronavirus Global Response partner countries will be part of the Facilitating Group.
Partnerske države na področju globalnega odziva na koronavirus bodo del te podporne skupine.
Three partnerships on vaccines, therapeutics and diagnostics are in the process of defining their strategy, resources needs and accountability rules.
Tri partnerstva na področju cepiv, terapevtike in diagnostike so v postopku opredeljevanja svoje strategije, potreb po sredstvih in pravil glede odgovornosti.
Each partnership will have two co-convenors, empowered and resourced to animate a partnership with all relevant actors (public sector, industry, research, funders, regulators, international organisations).
Vsako partnerstvo bo imelo dva koordinatorja, ki bosta pooblaščena in opremljena z ustreznimi viri za spodbujanje partnerstva z vsemi relevantnimi akterji (javni sektor, industrija, raziskave, financerji, regulatorji, mednarodne organizacije).
Who is taking part in the ACT-accelerator global response framework?
Kdo sodeluje v okviru za globalni odziv pospeševalnika ACT?
Each of the three partnerships aligns the actions of the actors involved, in a whole-value-chain approach (from research to delivery and universal access).
Vsako od treh partnerstev bo usklajevalo ukrepe vključenih akterjev v okviru pristopa, ki upošteva celotno vrednostno verigo (od raziskav do dobave in univerzalnega dostopa).
Global artists including Adam Lambert, Chloe x Halle, Chris Rock, Coldplay, Dionne Warwick, Femi Kuti, Fher of Maná, Hugh Jackman, Idris & Sabrina Elba, J Balvin, Justin Bieber, Lady Gaga, Lang Lang, Miley Cyrus, Padma Lakshmi, Rachel Brosnahan and Shakirahave announced that they would help rally citizens to the cause, so they can in turn take action and reach out to world leaders.
Svetovni umetniki, kot so Adam Lambert, Chloe x Halle, Chris Rock, Coldplay, Dionne Warwick, Femi Kuti, Fher iz skupine Maná, Hugh Jackman, Idris in Sabrina Elba, J Balvin, Justin Bieber, Lady Gaga, Lang Lang, Miley Cyrus, Padma Lakshmi, Rachel Brosnahan in Shakira, so napovedali, da bodo pomagali pritegniti državljane in državljanke k temu cilju, da bodo nato lahko ukrepali in se obrnili na svetovne voditelje.
The World Health Organisation is also a key partner and supporter in this endeavour.
Pri tem jih kot ključni partner podpira tudi Svetovna zdravstvena organizacija.
Progress made in the three priorities i.e. vaccines, therapeutics and diagnostics as well as work on strengthening health systems for coronavirus;
napredka na treh prednostnih področjih, tj. na področju cepiv, terapevtike in diagnostike, pa tudi pri krepitvi zdravstvenih sistemov za obvladovanje koronavirusa;
The vaccine, therapeutics and diagnostics partnerships will fully benefit from these complementarities.
Partnerstva na področju cepiv, terapevtike in diagnostike bodo v celoti izkoriščala te učinke dopolnjevanja.
Business partners will in principle not be required to forgo their intellectual property, but funding pledged will be accompanied by commitments from donors in support of global access and fair deployment of new diagnostics, treatment and vaccines against coronavirus.
Načeloma se od poslovnih partnerjev ne bo zahtevalo, da se odpovejo svoji intelektualni lastnini, vendar bodo donirana sredstva spremljale zaveze donatorjev v podporo globalnemu dostopu in pravičnemu uvajanju nove diagnostike, zdravljenja in cepiv proti koronavirusu.
The initiative aims to rally significant financial contributions to develop diagnostics, treatments and vaccines and secure a high-level political commitment to ensure equitable access to diagnostics, treatments and vaccines to make sure no one is left behind.
Namen pobude je zbrati znatne finančne prispevke za razvoj diagnostike, zdravljenja in cepiv ter zagotoviti politično zavezo na visoki ravni, da se zagotovi pravičen dostop do diagnostike, zdravljenj in cepiv, tako da ne bo nihče zapostavljen.
Almost €257 million through the COVID-19 Therapeutics Accelerator, initiative intended to enhance treatment development and deployment.
skoraj 257 milijonov evrov pobudi COVID-19 Therapeutics Accelerator, ki naj bi pospešila razvoj in uporabo zdravljenja;
More than 40 countries, United Nations bodies and philanthropies made a pledge towards the research and development of coronavirus solutions at this global event - with €7.4 billion equivalent to $8 billion - raised that day.
Več kot 40 držav, organi Združenih narodov in človekoljubne organizacije so se na tem globalnem dogodku zavezali, da bodo prispevali k raziskavam in razvoju rešitev za boj proti koronavirusu, in ta dan zbrali 7,4 milijarde evrov, kar je 8 milijard ameriških dolarjev.
Based on discussions with governmental and non-governmental partners, the European Commission has proposed a collaborative framework for the ACT-accelerator global response, as a coordination structure to steer and oversee progress made globally in accelerating work on the following three priorities: the development of vaccines, therapeutics and diagnostics with universal access, underpinned by strengthening of health systems needed for realising these priorities.
Evropska komisija je na podlagi razprav z vladnimi in nevladnimi partnerji predlagala okvir sodelovanja za globalni odziv pospeševalnika ACT v obliki usklajevalne strukture, ki bo usmerjala in nadzirala napredek na svetovni ravni pri pospeševanju dela na naslednjih treh prednostnih področjih: razvoju cepiv, terapevtike in diagnostike, ki bodo univerzalno dostopni; to bo podprto s krepitvijo zdravstvenih sistemov, ki je potrebna za uresničitev teh prioritet.
The European Commission committed €1 billion in grants and €400 million in guarantees on loans through reprioritisation of Horizon 2020 (€1 billion), RescEU (€80 million), the Emergency Support Instrument (€150 million).
Evropska komisija se je zavezala, da bo namenila milijardo evrov v obliki nepovratnih sredstev in 400 milijonov evrov v obliki poroštev za posojila, in sicer s ponovno določitvijo prednostnih nalog v okviru programa Obzorje 2020 (milijarda evrov), mehanizma RescEU (80 milijonov evrov) in instrumenta za nujno pomoč (150 milijonov evrov).
Coronavirus Global Response partner countries - France, Germany, Canada, Spain, Belgium, Austria, Morocco, South Africa, Mexico, Norway, South Africa, Saudi Arabia, Italy, New Zealand and the United Kingdom - as well as the European Investment Bank are supporting this campaign.
To kampanjo podpirajo partnerske države za globalni odziv na koronavirus - Avstrija, Belgija, Francija, Italija, Južna Afrika, Kanada, Maroko, Mehika, Nemčija, Norveška, Nova Zelandija, Saudova Arabija, Španija in Združeno kraljestvo - ter Evropska investicijska banka.
What is the ACT-accelerator global response framework?
Kaj je okvir za globalni odziv pospeševalnika ACT?
A group of governmental and private non-profit partners is being convened to facilitate the work of the vaccine, therapeutics and diagnostics partnerships and ensure coherence across the partnerships, report to donors and global fora on progress and advocate for additional resources needed and common solutions.
Oblikovala se bo skupina vladnih in zasebnih neprofitnih partnerjev, ki bo olajšala delo partnerstev na področju cepiv, terapevtike in diagnostike ter zagotovila skladnost v okviru partnerstev, poročala donatorjem in svetovnim forumom o napredku ter se zavzemala za dodatne potrebne vire in skupne rešitve.
Approximately €1.1 billion through the Coalition for Epidemic Preparedness Innovation (CEPI), for vaccine development and deployment.
približno 1,1 milijarde evrov koaliciji za inovacije na področju pripravljenosti na epidemije (CEPI) za razvoj cepiv in njihovo uporabo;
A transversal work stream, across the three partnerships, deals with supporting health systems in order to cope with coronavirus, in which the WHO will play a prominent role.
Prečni potek dela v vseh treh partnerstvih bo namenjen podpiranju zdravstvenih sistemov pri obvladovanju koronavirusa, pri čemer bo imela pomembno vlogo Svetovna zdravstvena organizacija.
They work as autonomously as possible, with a transversal work stream on health systems strengthening in relation to the coronavirus.
Partnerstva delujejo čim bolj avtonomno, s prečnim potekom dela za krepitev zdravstvenih sistemov za obvladovanje koronavirusa.
This is why, on 4 May, President von der Leyen invited people to continue joining the Coronavirus Global Response, "in a global mobilisation of hope and resolve."
Zato je predsednica Komisije Ursula von der Leyen 4. maja pozvala ljudi, naj se „v globalnem duhu upanja in odločnosti" tudi v prihodnje pridružijo globalnemu odzivu na koronavirus.
With this in mind, on 24 April, the World Health Organization (WHO) and an initial group of health actors launched a global collaboration for the accelerated development, production and equitable global Access to COVID-19 Tools - the ACT Accelerator.
S tem vodilom sta Svetovna zdravstvena organizacija (SZO) in prva skupina zdravstvenih akterjev 24. aprila začeli globalno sodelovanje za pospešen razvoj, proizvodnjo in pravičen globalni dostop do orodij za COVID-19 - pospeševalnik ACT. Skupaj so objavili poziv k ukrepanju .